Reckitt Benckiser Group (LON:RKT – Get Free Report)‘s stock had its “neutral” rating reissued by investment analysts at Royal Bank Of Canada in a research note issued on Friday,London Stock Exchange reports. They presently have a GBX 6,200 price target on the stock. Royal Bank Of Canada’s target price points to a potential upside of 35.70% from the company’s previous close.
A number of other research analysts also recently commented on RKT. Citigroup reduced their price target on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a report on Thursday, April 23rd. Jefferies Financial Group restated a “hold” rating and set a GBX 5,600 price objective on shares of Reckitt Benckiser Group in a report on Tuesday. Berenberg Bank cut their target price on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a research report on Friday, April 24th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on Reckitt Benckiser Group from GBX 5,460 to GBX 5,430 and set a “hold” rating for the company in a research note on Tuesday, April 28th. Three equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of GBX 6,204.29.
View Our Latest Stock Report on RKT
Reckitt Benckiser Group Stock Up 0.5%
Reckitt Benckiser Group (LON:RKT – Get Free Report) last announced its earnings results on Thursday, March 5th. The company reported £122.58 earnings per share for the quarter. Reckitt Benckiser Group had a return on equity of 38.45% and a net margin of 25.23%. On average, equities analysts anticipate that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current year.
Insider Activity at Reckitt Benckiser Group
In related news, insider Kris Licht sold 5,435 shares of Reckitt Benckiser Group stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of GBX 4,753, for a total value of £258,325.55. Insiders own 0.44% of the company’s stock.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- 3 AI Data Center Stocks Worth Watching for Capital Rotation
- McDonald’s Is the Cheapest It’s Been in Years—Does That Make It a Buy?
- Karman: Defense Darling’s Outlook Strengthens After 40% Drop
- Aeluma’s Post-Earnings Dip Creates a Buying Opportunity
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
